111In-XYIMSR-01
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 111In-XYIMSR-01, covering 2025-07-23 to 2025-07-23. Get the full timeline:
Most recent: Clinical Trial Update: Study of 111In-XYIMSR-01 SPECT/CT in Patients With Metastatic Clear Cell Renal Cell [Phase 1]